4th Quarter - Report

CHILDREN'S HEALTHCARE OF ATLANTA for CHILDREN'S HEALTHCARE OF ATLANTA

Firm
Client
Income
—
Expenses
$118,118
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicaid program reforms, including telemedicine Section 340B Drug Pricing Program Sickle Cell Disease research funding generally Drug pricing reforms generally Reauthorization of Children's Hospital Graduate Medical Education program Mental and behavioral health legislation generally H.R. 4943 (Children's Mental Health Infrastructure Act of 2021), all provisions H.R. 4944 (Helping Kids Cope Act of 2021), all provisions H.R. 5585 (Advanced Research Project Agency-Health Act), all provisions H.R. 7236 (Strengthen Kids' Mental Health Now Act of 2022), all provisions H.R. 7666 (Restoring Hope for Mental Health and Well-Being Act of 2022), all provisions H.R. 6972 (Give Kids a Chance Act of 2022), all provisions H.R. 7667 (Food and Drug Amendments of 2022), all provisions H.R. 5131 and S. 2762 (PATCH Act), all provisions H.R. 1916 (Ensuring Lasting Smiles Act), all provisions S. 4348 (FDASLA Act of 2022), Title VIII, Subtitle C, regarding regulation of in vitro clinical tests S. 4472 (Health Care Capacity for Pediatric Mental Health) S. 4747 (Investing in Kids Mental Health Now Act) Children's Health Insurance Program (CHIP), regarding continuous elgibility

LobbyistCovered position, as disclosed
JAMILA POPE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1916 (117th), H.R. 4944 (117th), S. 2762 (117th), H.R. 5131 (117th), H.R. 5585 (117th), H.R. 7667 (117th), H.R. 7666 (117th), H.R. 4943 (117th), H.R. 6972 (117th), S. 4348 (117th), H.R. 7236 (117th), S. 4472 (117th), S. 4747 (117th)

Budget/Appropriations BUD

Autism research programs and autism intervention programs generally, including Department of Justice program on elopement Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 8295 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023) Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, and other programs related to pediatric health care H.R. 2617 (Consolidated Appropriations Act, 2023), Division H, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) Program, sickle cell disease research, Advanced Research Projects Agency-Health,and other programs related to pediatric health care

LobbyistCovered position, as disclosed
JAMILA POPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8295 (117th), H.R. 2617 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.